ASML (NASDAQ:ASML) Reports Record Quarterly Sales as Semiconductor Equipment Demand Surges

Aditi Sarkar

11 November 2026 03:14 PM AEDT

ASML (NASDAQ:ASML) Reports Record Quarterly Sales as Semiconductor Equipment Demand Surges

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Q3 2026 net sales reached a record €11.7 billion, up 55% year-over-year, with Net Income of €5.0 billion and gross Margin of 57.5%.
ASML sold 113 new lithography systems in the quarter and guided Q4 2026 Revenue to between €14.2 billion and €15.2 billion.
Full-year 2026 guidance was revised upward to €44 billion–€45 billion, reflecting strong customer Demand through the semiconductor Investment cycle.
Supply is expected to remain constrained relative to demand through 2028, with ASML investigating capacity expansion beyond its already-planned 30% increase.

ASML (NASDAQ:ASML), the Netherlands-based semiconductor equipment manufacturer and sole supplier of extreme ultraviolet (EUV) lithography systems, reported record third-quarter 2026 financial results as global demand for advanced chip Manufacturing tools reached new heights. Q3 2026 net sales reached a record €11.7 billion, up 55% year-over-year, with net income of €5.0 billion and gross margin of 57.5%.

Record Sales Driven by Advanced Lithography Demand

Net sales for the third quarter ended September 2026 came in at €11.7 billion, a 55% increase year-over-year, with net income of €5.0 billion. Gross margin was 57.5% for the quarter, reflecting healthy pricing power and product mix. Basic Earnings Per Share reached €12.95. Installed Base Management (IBM) sales — which cover maintenance, upgrades, and service for ASML's installed equipment — contributed €3.3 billion, underscoring the growing Recurring Revenue component of the Business as the installed base expands.

The company sold 113 new lithography systems during Q3, with the mix weighted toward its most advanced EUV and high-NA EUV platforms. Customer demand for systems supporting both leading-edge logic and memory applications has remained broad-based, driven by artificial intelligence workloads requiring the most sophisticated chip designs.

Supply Constraints Persist Amid Surging Demand

ASML management noted that customers are already placing orders for delivery in 2029 and 2030, reflecting the multi-year visibility the company has into its backlog. Supply is not expected to fully meet demand through at least 2028. In response, ASML is investigating the feasibility of expanding manufacturing capacity beyond its already-announced 30% capacity increase planned for 2028. The bottleneck primarily reflects the complexity and time required to ramp production of leading-edge optical and mechanical components used in high-NA EUV systems.

Strong Q4 Guidance and Full-Year Upgrade

For the fourth quarter of 2026, ASML guided net sales of between €14.2 billion and €15.2 billion, implying continued sequential growth. Full-year 2026 guidance was set at €44 billion–€45 billion, representing a material upgrade from prior forecasts. The guidance reflects the company's confidence in its ability to convert Backlog into recognised revenue at an accelerating pace through the remainder of the fiscal year.

Shareholder Returns and Dividend

ASML declared an interim Dividend of €1.88 per share during the quarter, reinforcing its commitment to returning Capital to shareholders even as it invests in capacity expansion. The company's Monopoly position in advanced EUV lithography continues to provide significant competitive insulation, with no credible alternative supplier for the most advanced chip manufacturing nodes currently available globally.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.